|
Symbol
|
AWSBIL | ZYALTQ | SKS4LK | OVCRCH | OZTRCH | Z0A4JZ | AANOTQ | ABVHSQ | AYSBIL | LXORLK | Z0ATYZ | CQWBKB | ACDQTQ | RMAKRV | RMAG0V | Z0B7EZ | UJERWU | LZPRCH | RMBGJV | RMBU5V |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Reverse Convertible | Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible | Multi Reverse Convertible | Autocallable Multi Vonti | Autocallable Multi Vonti | Autocallable Reverse Convertible Defensive worst | GOAL | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti |
|
Underlying
|
Compagnie Financière Richemont SA / Logitech International SA / Sika AG / Straumann Hldg. AG | Givaudan / Sonova Hldg. AG / Straumann Hldg. AG | Julius Baer Group / Roche AG / Straumann Hldg. AG | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Kühne & Nagel Intl. AG / Straumann Hldg. AG / VAT Group | ABB / Holcim/Amrize Basket / Straumann Hldg. AG | Adecco Group AG / OC Oerlikon N / Straumann Hldg. AG / VAT Group | Sika AG / Helvetia Baloise Holding AG / Straumann Hldg. AG / Sandoz Group AG | Alcon / Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Givaudan / Julius Baer Group / Straumann Hldg. AG | Alcon / Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Lonza Group N / Novartis N / Roche GS / Straumann Hldg. AG | Adecco Group AG / Logitech International SA / Stadler Rail AG / Straumann Hldg. AG / UBS Group AG | Lonza Group N / Sika AG / Straumann Hldg. AG | Lonza Group N / Sika AG / Straumann Hldg. AG | Alcon / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG | SGS S.A. Ltd. / Sika AG / Straumann Hldg. AG | Alcon / Lonza Group N / Novartis AG / Straumann Hldg. AG | Lonza Group N / Novartis AG / Straumann Hldg. AG / Ypsomed Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
23.10.2026 | 02.11.2026 | 10.07.2026 | 09.06.2026 | 07.04.2026 | 30.03.2026 | 27.09.2029 | 07.10.2026 | 22.04.2027 | 05.03.2027 | 05.03.2027 | 13.03.2028 | 21.03.2030 | 24.06.2026 | 24.06.2026 | 10.12.2026 | 02.08.2027 | 07.08.2029 | 19.08.2027 | 22.02.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Strike price
|
70.148 | 177.33 | 184.50 | 76.59 | 162.33 | 100.793 | 18.304 | 183.04 | 90.86 | 2,812.194 | 31.4067 | 378.0225 | 74.3275 | 441.20 | 419.30 | 81.90 | 75.3422 | 150.75 | 406.20 | 292.70 |
| Max. yield p.a. | 8.08% | 16.18% | 11.45% | 17.28% | 29.63% | 34.30% | 12.47% | 22.88% | 19.37% | 12.03% | 17.89% | 7.37% | 9.44% | 33.43% | 25.13% | 19.23% | 11.06% | 7.24% | 8.08% | 11.04% |
| Bid | - | 91.28 | - | - | 93.55 | - | - | 87.25 | - | - | - | 94.89 | 85.92 | 88.70 | 92.10 | - | 91.60 | - | 96.60 | 92.50 |
| Ask | - | 92.08 | - | - | 94.35 | - | - | 88.05 | - | - | - | 95.69 | 86.72 | 89.70 | 93.10 | - | 92.60 | - | 97.40 | 93.50 |